Top Page
Meituan
(OTC:3690)
Meituan (3690) vs. iShares MSCI Hong Kong ETF (EWH)
Meituan Business Overview & Revenue Model
Meituan Earnings Call Summary
Meituan Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 337.59B | 276.74B | 219.95B | 179.13B | 114.79B | Gross Profit |
| 129.78B | 97.19B | 61.75B | 42.47B | 34.05B | EBIT |
| 36.84B | 13.42B | -5.13B | -21.99B | -521.75M | EBITDA |
| 41.51B | 23.44B | 4.56B | -13.56B | 4.67B | Net Income Common Stockholders |
| 35.81B | 13.86B | -6.69B | -23.54B | 4.71B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 168.24B | 145.16B | 112.03B | 116.80B | 61.09B | Total Assets |
| 324.35B | 293.03B | 244.48B | 240.65B | 166.57B | Total Debt |
| 61.51B | 60.62B | 58.09B | 58.92B | 24.06B | Net Debt |
| -9.32B | 27.28B | 37.93B | 26.41B | 6.96B | Total Liabilities |
| 151.75B | 141.07B | 115.78B | 115.10B | 68.94B | Stockholders Equity |
| 172.66B | 152.01B | 128.76B | 125.61B | 97.69B |
| Cash Flow | Free Cash Flow | |||
| 46.15B | 33.64B | 5.68B | -13.02B | -7.35B | Operating Cash Flow |
| 57.15B | 40.52B | 11.41B | -4.01B | 8.48B | Investing Cash Flow |
| 10.21B | -24.66B | -14.71B | -58.49B | -21.23B | Financing Cash Flow |
| -30.41B | -2.78B | -9.99B | 78.60B | 17.42B |
Meituan Technical Analysis
Meituan Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$2.17T | 15.31 | 13.02% | 0.86% | 3.92% | 27.80% | |
80 Outperform | HK$404.50B | 8.05 | 19.79% | 3.02% | 7.67% | 90.63% | |
69 Neutral | HK$834.59B | 19.55 | 23.82% | ― | 19.20% | 156.71% | |
62 Neutral | $6.93B | 11.25 | 2.95% | 3.88% | 2.69% | -24.71% | |
48 Neutral | HK$1.34B | ― | -4.60% | ― | 5.61% | 29.83% |
Meituan Corporate Events
Meituan has reported a significant increase in its financial performance for the first quarter of 2025, with revenues rising by 18.1% to RMB 86.6 billion compared to the same period in 2024. The company’s operating profit more than doubled, reaching RMB 10.6 billion, driven by strong growth in its core local commerce and new initiatives segments, indicating a robust market position and potential for future expansion.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has announced the appointment of Ms. Yang Marjorie Mun Tak as a member of its Nomination Committee, effective May 26, 2025. This strategic appointment is expected to enhance the governance structure of the company, potentially impacting its decision-making processes and reinforcing its commitment to maintaining robust corporate governance practices.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes both executive and independent non-executive directors, with specific individuals assigned to various board committees such as audit, remuneration, nomination, and corporate governance. This announcement provides insights into the governance structure of Meituan, potentially impacting its strategic direction and stakeholder confidence.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has updated the terms of reference for its Nomination Committee, which was originally established in 2018. The committee is responsible for identifying and recommending candidates for the board of directors, overseeing board performance evaluations, and developing nomination guidelines. The committee is composed mainly of independent non-executive directors, ensuring compliance with Hong Kong Stock Exchange listing rules. These updates aim to enhance the governance structure and ensure a diverse and effective board, which could strengthen Meituan’s industry positioning and stakeholder confidence.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has announced proposed amendments to its Articles of Association to align with the Core Shareholder Protection Standards and Corporate Governance Code of the Hong Kong Stock Exchange. These amendments aim to facilitate virtual shareholder meetings and electronic voting, update the nomination committee’s terms of reference, and make other clarifications. The adoption of these amendments is subject to shareholder approval at the upcoming annual general meeting in June 2025.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has announced its upcoming annual general meeting scheduled for June 9, 2025, where key resolutions will be considered. These include the adoption of financial statements for 2024, re-election of independent non-executive directors, and authorization for the board to manage director remuneration and issue additional Class B shares. This meeting is crucial for Meituan’s strategic planning and governance, potentially impacting its market operations and shareholder interests.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has announced that its board of directors will hold a meeting on May 26, 2025, to consider and approve the unaudited financial results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:3690) stock is a Buy with a HK$130.00 price target. To see the full list of analyst forecasts on Meituan stock, see the HK:3690 Stock Forecast page.
Meituan has announced the grant of 30,532,990 restricted share units (RSUs) as part of its Post-IPO Share Award Scheme. The RSUs are allocated to employee participants and service providers, with a vesting period ranging from 24 to 48 months for employees and 24 to 36 months for service providers. This initiative aims to align the interests of the grantees with the company’s long-term growth and profitability, encouraging contributions towards enhancing the company’s value.
Meituan Dianping reported a significant financial performance improvement for the year ended December 31, 2024, with a 22% increase in revenues and a substantial rise in operating profit by 174.6% compared to the previous year. The company’s adjusted EBITDA and net profit also saw impressive growth, indicating strong operational efficiency and market positioning, which could positively impact stakeholders and reinforce its competitive edge in the service industry.
Meituan has announced that its board of directors will hold a meeting on March 21, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, impacting stakeholders and potentially influencing its market position.